lexiara

Article 21

An authorisation to market a proprietary medicinal product shall not be refused, suspended or revoked except on the grounds set out in this Directive.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-05 · Text as adopted (Official Journal); later amendments are not incorporated in this text.